Follows previous agreements signed in November 2018 and July 2019

Submission is based on data from the pivotal SYNAPSE study

Updated data from DESTINY-Breast01 trial continued to demonstrate duration of response

Updated guidance warns people with a history of allergic reactions not to receive the shot

A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, […]

Updated Date: Wed, 02 Dec 2020 00:00:00 EST

Updated Date: Wed, 02 Dec 2020 00:00:00 EST

Updated Date: Wed, 02 Dec 2020 00:00:00 EST

Updated Date: Wed, 02 Dec 2020 00:00:00 EST

Updated Date: Wed, 02 Dec 2020 00:00:00 EST